AC Immune (ACIU) Treasury Shares (2020 - 2026)
AC Immune (ACIU) posted quarterly Treasury Shares of -$278.4 million for Q1 2026, down 114712.68% year-over-year from N/an in Q1 2025, and down 2.06% quarter-over-quarter from -$272.8 million in Q4 2025.
AC Immune (ACIU) Treasury Shares (2020 - 2026) Analysis & Trends
AC Immune (ACIU) has reported Treasury Shares for 7 consecutive years, with -$278.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Treasury Shares fell 114712.68% year-over-year to -$278.4 million; the TTM figure through Mar 2026 stood at -$278.4 million (down 114712.68% YoY), while the FY2025 annual figure was -$262.9 million, down 105559.69% from the prior year.
- Treasury Shares eased to -$278.4 million in Q1 2026 per ACIU's latest filing, from -$272.8 million in the prior quarter.
- Across five years, Treasury Shares topped out at $13.6 million in Q4 2025 and bottomed at $5.9 million in Q4 2023.
- Historically, Treasury Shares has averaged $9.2 million across 5 years, with a median of $6.7 million in 2021.
- Annual changes were most pronounced in 2022 — Treasury Shares soared 100.1% — and 2026, when it sank 114712.68%.
- AC Immune's Treasury Shares stood at $128714.7 in 2022, then plunged by 92064.79% to -$118.4 million in 2023, then jumped by 99.79% to -$248851.8 in 2024, then tumbled by 109505.42% to -$272.8 million in 2025, then declined by 2.06% to -$278.4 million in 2026.
- Business Quant data shows ACIU's Treasury Shares at -$278.4 million in Q1 2026, -$272.8 million in Q4 2025, and -$272523.9 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.08 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.72 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 92,219.00 |
| 10 | AC Immune | 253.89 Mn | 253.89 Mn | - | 269,495.93 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.51 Mn |
| Jun 30, 2026 | 269,495.93 |
| Jun 30, 2026 | 13.51 Mn |
| Jun 30, 2026 | 269,495.93 |
| Mar 31, 2026 | -278.39 Mn |
| Mar 31, 2026 | -278.39 Mn |
| Dec 31, 2025 | 13.64 Mn |
| Dec 31, 2025 | -272.76 Mn |
| Dec 31, 2025 | -272.76 Mn |
| Dec 31, 2025 | 13.64 Mn |
| Sep 30, 2025 | -272,523.87 |
| Sep 30, 2025 | -272,523.87 |
| Jun 30, 2025 | 13.17 Mn |
| Jun 30, 2025 | -263,320.07 |
| Jun 30, 2025 | 13.17 Mn |
| Jun 30, 2025 | -263,320.07 |
| Mar 31, 2025 | -242,470.62 |
| Mar 31, 2025 | -242,470.62 |
| Dec 31, 2024 | 12.44 Mn |
| Dec 31, 2024 | -248,851.76 |